Handbook home
Frontiers in Genomics (GENE90024)
Graduate courseworkPoints: 6.25On Campus (Parkville)
About this subject
- Overview
- Eligibility and requirements
- Assessment
- Dates and times
- Further information
- Timetable(opens in new window)
Contact information
Overview
Availability | Semester 2 |
---|---|
Fees | Look up fees |
This subject will examine the role of genomics and precision medicine in gene-based therapies.
Module 1 will focus on emerging treatments for cancer, with Module 2 exploring the role of emerging technologies in the diagnosis and treatment in genomic medicine.
Intended learning outcomes
At the completion of this subject, students will be able to:
- Demonstrate an ability to interpret human genomic information in a clinical setting
- Discuss the value of genomic testing in management of disease
- Illustrate the relevance and utility of advances in technology to a particular healthcare setting
Last updated: 3 November 2022
Eligibility and requirements
Prerequisites
Students must have completed GENE90001 Human Genetics and Genomics in Healthcare to H2B (70%) and GENE90002 Clinical Genomics to H2B (70%) or equivalent
Corequisites
None
Non-allowed subjects
None
Inherent requirements (core participation requirements)
The University of Melbourne is committed to providing students with reasonable adjustments to assessment and participation under the Disability Standards for Education (2005), and the Assessment and Results Policy (MPF1326). Students are expected to meet the core participation requirements for their course. These can be viewed under Entry and Participation Requirements for the course outlines in the Handbook.
Further details on how to seek academic adjustments can be found on the Student Equity and Disability Support website: http://services.unimelb.edu.au/student-equity/home
Last updated: 3 November 2022
Assessment
Description | Timing | Percentage |
---|---|---|
Module 1: Precision Medicine and Pharmacogenetics 15 minute quiz
| First half of the teaching period | 10% |
Module 2: Emerging technologies: EITHER Individual Presentation, 10mins; OR Written assessment 1000 words
| End of semester | 40% |
Module 2: Emerging technologies 15 minute quiz
| Second half of the teaching period | 10% |
Module 1: Precision Medicine and Pharmacogenetics: EITHER Individual Presentation, 10mins; OR Written assessment 1000 words
| Mid semester | 40% |
Last updated: 3 November 2022
Dates & times
- Semester 2
Principal coordinator Jan Hodgson Coordinator Helen Dedman Mode of delivery On Campus (Parkville) Contact hours Total time commitment 85 hours Teaching period 29 July 2019 to 27 October 2019 Last self-enrol date 9 August 2019 Census date 31 August 2019 Last date to withdraw without fail 27 September 2019 Assessment period ends 22 November 2019
Last updated: 3 November 2022
Further information
- Texts
Prescribed texts
There are no specifically prescribed or recommended texts for this subject.
Last updated: 3 November 2022